• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Magle Chemoswed

1.18 SEK

-31.40 %

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-31.40 %
-72.04 %
-84.47 %
-93.30 %
-93.30 %
-95.53 %
-96.50 %
-96.80 %
-94.13 %

Magle Chemoswed is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes three operational areas. Magle Chemoswed, a contract development and manufacturing organization (CDMO). Magle PharmaCept, an established sales and marketing company for the development and direct sales of the Groups medical technology products, and Magle Biopolymers A/S, a specialized manufacturing organization of Dextran technology.

Read more
Market cap
35.71M SEK
Turnover
297.75K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5.8.
2026

Interim report Q2'26

2.11.
2026

Interim report Q3'26

24.2.
2027

Annual report '26

Regulatory press release6/7/2026, 5:08 PM

Magle Chemoswed Holding AB – Update on Financing Arrangements and Ongoing Stakeholder Discussions

Magle Chemoswed
Regulatory press release6/7/2026, 1:25 PM

Magle Group Announces Change in Publication Date for Annual Report 2025

Magle Chemoswed
Press release6/3/2026, 1:13 PM

Redeye: Magle Group (Q1 Review): Restructured operations, focus on turnaround

Magle Chemoswed

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release6/2/2026, 12:28 PM

Magle Chemoswed Holding AB (publ) initiates a written procedure to amend the terms and conditions of its senior secured bonds 2025/2028

Magle Chemoswed
Regulatory press release5/31/2026, 10:00 AM

Magle Chemoswed Holding Reports Financial Results For First Quarter 2026

Magle Chemoswed
Regulatory press release5/28/2026, 6:32 AM

Notice to the Annual General Meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/27/2026, 5:26 PM

Magle Group enters into a loan facility agreement of up to SEK 60 million

Magle Chemoswed
Regulatory press release5/26/2026, 2:28 PM

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/25/2026, 1:00 PM

Calendar Update of the Annual General Meeting 2026

Magle Chemoswed
Regulatory press release5/11/2026, 8:01 PM

MAGLE GROUP HAS RESOLVED ON A SET-OFF ISSUE TO BONDHOLDERS

Magle Chemoswed
Regulatory press release5/8/2026, 7:30 AM

Notice to extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release5/5/2026, 6:31 PM

Magle Group announces resignation of board member

Magle Chemoswed
Regulatory press release5/1/2026, 3:26 PM

Magle Group announces resignation of board members

Magle Chemoswed
Regulatory press release4/30/2026, 4:04 PM

Magle Group Announces Outcome of Rights Issue

Magle Chemoswed
Regulatory press release4/28/2026, 5:30 AM

Magle Group Announces Change in Publication Date for Annual Report 2025

Magle Chemoswed
Regulatory press release4/23/2026, 6:51 PM

Magle Chemoswed Holding AB (publ) announces successful completion of the written procedure in relation to its senior secured bonds 2025/2028

Magle Chemoswed
Regulatory press release4/14/2026, 7:28 AM

Magle Group Publishes Information Document in Connection with Upcoming Rights Issue

Magle Chemoswed
Regulatory press release4/10/2026, 9:27 AM

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ)

Magle Chemoswed
Regulatory press release3/27/2026, 7:30 AM

Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2025

Magle Chemoswed
Regulatory press release3/26/2026, 3:35 PM

Magle Chemoswed Holding AB (publ) initiates written procedure to amend the terms and conditions of its senior secured bonds 2025/2028

Magle Chemoswed